The Lancet Infectious Diseases | Journal | ScienceDirect.com by Elsevier

Go to journal home page - The Lancet Infectious Diseases

Submit your article Guide for authors

Latest issue

Volume 22, Issue 3

March 2022

About the journal

The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide.

As the global leader in clinical infectious diseases, The …

1.6 weeks

Time to First Decision

2 weeks

Review Time

Editor-in-Chief

View full Editorial Board

John McConnell

Articles

DiscussionNo access

Triple artemisinin-based combination therapies for malaria: a timely solution to counter antimalarial drug resistance

Ingrid Chen, Michelle S Hsiang

In Press, Corrected Proof, Available online 8 March 2022

Research articleOpen access

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

Thomas J Peto, ... Arjen M Dondorp

In Press, Corrected Proof, Available online 8 March 2022

DiscussionFull text access

COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA

Matthew S Krantz, Elizabeth J Phillips

In Press, Corrected Proof, Available online 7 March 2022

Research articleFull text access

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

Hannah G Rosenblum, ... David K Shay

In Press, Corrected Proof, Available online 7 March 2022

Review articleFull text access

25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward

Anna S Dean, ... Katherine Floyd

In Press, Corrected Proof, Available online 3 March 2022

DiscussionFull text access

World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis

Francine Ntoumi, ... Alimuddin Zumla

In Press, Corrected Proof, Available online 3 March 2022

Review articleAbstract only

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

Saartje Uyttebroek, ... Willem-Jan Metsemakers

In Press, Corrected Proof, Available online 3 March 2022

ErratumFull text access

Correction to Lancet Infect Dis 2022; published online Jan 19. https://doi.org/10.1016/S1473-3099(21)00587-9

In Press, Corrected Proof, Available online 3 March 2022

More articles in press

More from The Lancet Infectious Diseases

29 June 2020

Elsevier Coronavirus Research Hub

View all announcements

Article collections

Preview Issue

April 2001

View all article collections

View all issues

Related journals

1473-3099

ISSN

Copyright © 2022 Elsevier Ltd. All rights reserved